Evidence map›Paper›PMID 24461367›Full record

ReviewSurvey of ophthalmology

Corneal nerves in health and disease.

Brittany Simmons Shaheen, May Bakir, Sandeep Jain

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Survey of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04125134 (Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests), which is not on this map. Cited by 245 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 3 pooled it
26.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04125134 phase4terminatednot on this map

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

TypeinterventionalSponsorTufts Medical CenterRan2019 to 2025Enrolled36ConditionsDry EyeArmsPreservative-free Refresh Optive Advanced Lubricant Eye Drops
3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 3 syntheses or guidelines pooled it, 461 citations in OpenAlex.

  1. Topical ophthalmic anesthetics for corneal abrasions.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brittany Simmons ShaheenCorneal Neurobiology Laboratory, Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
May BakirCorneal Neurobiology Laboratory, Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Sandeep JainCorneal Neurobiology Laboratory, Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois. Electronic address: Jains@uic.edu.
University of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YAO, XINCHENG · 1985 to 2025
$14.8M
Molecular and Cellular Aspects of Corneal Nerve RegenerationR01EY023656 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAIN, SANDEEP · 2013 to 2017
$2.6M
Keratocyte role in guidance of corneal nervesK08EY018874 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAIN, SANDEEP · 2009 to 2013
$1.4M
NEI NIH HHS K08 EY018874NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY023656
6 · The paper itself

Abstract

Corneal nerves are responsible for the sensations of touch, pain, and temperature and play an important role in the blink reflex, wound healing, and tear production and secretion. Corneal nerve dysfunction is a frequent feature of diseases that cause opacities and result in corneal blindness. Corneal opacities rank as the second most frequent cause of blindness. Technological advances in in vivo corneal nerve imaging, such as optical coherence tomography and confocal scanning, have generated new knowledge regarding the phenomenological events that occur during reinnervation of the cornea following disease, injury, or surgery. The recent availability of transgenic neurofluorescent murine models has stimulated the search for molecular modulators of corneal nerve regeneration. New evidence suggests that neuroregenerative and inflammatory pathways in the cornea are intertwined. Evidence-based treatment of neurotrophic corneal diseases includes using neuroregenerative (blood component-based and neurotrophic factors), neuroprotective, and ensconcing (bandage contact lens and amniotic membrane) strategies and avoiding anti-inflammatory therapies, such as cyclosporine and corticosteroids.

Indexed as

AnimalsCorneaCorneal DiseasesHumansNerve Growth FactorsNerve RegenerationOphthalmic NerveNerve Growth Factorscorneal nervesinflammationnerve regenerationneuropathic painneurotrophic keratitis

Identifiers

PMID24461367
PMCPMC4004679
OpenAlexW2048729493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.